Health
FDA authorizes marketing of a new device for use in patients undergoing stroke rehabilitation – News-Medical.Net
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to…
Today, the U.S. Food and Drug Administration authorized marketing of a new device indicated for use in patients 18 and older undergoing stroke rehabilitation to facilitate muscle re-education and for maintaining or increasing range of motion. The Neurolutions IpsiHand Upper Extremity Rehabilitation System (IpsiHand System) is a Brain-Computer-Interface (BCI) device that assists in rehabilitation for stroke patients with upper extremity—or hand, wrist and arm—disability.
Thousands of stroke survivors…
-
Noosa News24 hours agoQueensland man sentenced to four years imprisonment after string of terror offences
-
Business24 hours agoThe best ASX ETFs for compounding wealth until 2040
-
Noosa News22 hours agoMeasles alert issued south of Brisbane after traveller tests positive
-
General23 hours agoThe energy grid needs markets, not mandates!